company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 12:56:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27370000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 12:56:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.39
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 12:56:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27370000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 12:56:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.37
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 12:56:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27370000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 12:56:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.39
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 14:58:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27431000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 14:58:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.4
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 14:58:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27431000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 14:58:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.38
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 14:58:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27431000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 14:58:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.4
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,454234000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,454234000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,197107000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,197107000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,257127000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,153617000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,40263000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,193880000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,63247000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,14444000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1016000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13428000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,49819000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14427000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,35392000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,35392000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,531000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,34861000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27545000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.27
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28072000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.24
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27400000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.27
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2,2010-04-01,2010-06-30,2010-08-06 12:56:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27606000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2,2010-04-01,2010-06-30,2010-08-06 12:56:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.37
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2,2010-04-01,2010-06-30,2010-08-06 12:56:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27606000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2,2010-04-01,2010-06-30,2010-08-06 12:56:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.35
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2,2010-04-01,2010-06-30,2010-08-06 12:56:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27606000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2,2010-04-01,2010-06-30,2010-08-06 12:56:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.37
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3,2010-07-01,2010-09-30,2010-11-09 14:58:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27697000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3,2010-07-01,2010-09-30,2010-11-09 14:58:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.62
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3,2010-07-01,2010-09-30,2010-11-09 14:58:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27697000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3,2010-07-01,2010-09-30,2010-11-09 14:58:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.59
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3,2010-07-01,2010-09-30,2010-11-09 14:58:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27697000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3,2010-07-01,2010-09-30,2010-11-09 14:58:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.62
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1472884000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1472884000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,638523000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,638523000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,834361000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,481596000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,132003000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,613599000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,220762000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,49273000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1025000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-50298000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,170464000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,18921000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,151543000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,151543000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,914000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,150629000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27665000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.44
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28151000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.41
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27700000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.44
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,485121000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,485121000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,207510000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,207510000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,277611000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,167763000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,42730000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,210493000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,67118000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16766000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2091000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-18857000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,48261000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15323000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,32938000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,32938000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-101000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,33039000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27904000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.18
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28389000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.16
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.18
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,521656000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,521656000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,228520000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,228520000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,293136000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,176740000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,48210000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,224950000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,68186000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12041000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1674000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10367000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,57819000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17797000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,40022000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,40022000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-26000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,40048000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28014000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.43
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28495000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.41
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.43
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,516514000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,516514000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,220338000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,220338000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,296176000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,176867000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,45387000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,222254000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,73922000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12341000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5808000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-18149000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,55773000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9911000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,45862000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,45862000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-35000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,45897000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28072000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.63
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28456000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.61
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.63
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,550238000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,550238000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,238332000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,238332000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,311906000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,174614000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,41277000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,215891000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,96015000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11987000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-34000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-12021000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,83994000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,24003000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,59991000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,59991000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-38000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,60029000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28031000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.15
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28468000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.11
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.15
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,486277000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,486277000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,207695000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,207695000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,278582000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,171293000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52923000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,224216000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,54366000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,13196000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5009000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8187000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,46179000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15235000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,30944000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,30944000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-61000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,31005000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28201000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.1
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28553000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.09
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.1
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,510422000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,510422000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,222522000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,222522000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,287900000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,162256000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52336000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,214592000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,73308000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12401000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5112000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7289000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,66019000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17454000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,48565000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,48565000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,222000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,48343000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28250000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.71
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28610000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.69
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28300000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.71
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,498697000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,498697000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,225187000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,225187000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,273510000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,160274000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,49004000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,209278000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,64232000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11901000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1063000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10838000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,53394000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11023000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,42371000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,42371000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-13000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,42384000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28312000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.5
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28645000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.48
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28300000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.5
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,573839000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,573839000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,258673000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,258673000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,315166000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,187955000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,54941000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,242896000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,72270000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,13614000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5659000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7955000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,64315000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,20649000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,43666000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,43666000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-79000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,43745000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28290000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.54
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28642000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.52
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28300000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.54
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,499672000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,499672000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,228260000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,228260000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,271412000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,185917000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,51941000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,237858000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,33554000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10977000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-128000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11105000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,22449000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2929000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,19520000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,19520000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,21000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,19499000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28494000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.68
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28817000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.68
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28700000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.68
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,525321000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,525321000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,225220000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,225220000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,300101000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,195331000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,51841000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,247172000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,52929000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11664000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,7779000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3885000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,49044000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14442000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,34602000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,34602000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,34602000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28538000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.21
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28868000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.2
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28600000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.21
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,505066000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,505066000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,220850000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,220850000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,284216000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,202238000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52920000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,255158000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,29058000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,31611000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2663000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-34274000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5216000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1883000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7099000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7099000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7099000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28603000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28603000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28400000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,602635000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,602635000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,279886000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,279886000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,322749000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,214584000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,54250000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,268834000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,53915000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7019000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-788000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7807000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,46108000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15320000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,30788000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,30788000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,30788000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28586000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.08
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28906000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.06
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28600000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.08
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,509344000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,509344000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,234055000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,234055000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,275289000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,202275000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52543000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,254818000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,20471000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3857000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2076000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5933000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,14538000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7870000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6668000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6668000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6668000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28791000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.23
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29059000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.23
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.23
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,536832000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,536832000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,239590000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,239590000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,297242000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,195838000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,55717000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,251555000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,45687000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5564000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,8674000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3110000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,48797000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17166000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,31631000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,31631000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,31631000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28826000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.1
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29092000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.09
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.1
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,530644000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,530644000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,242068000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,242068000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,288576000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,202550000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52786000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,255336000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,33240000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7710000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3054000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10764000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,22476000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10967000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11509000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11509000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11509000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28884000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.4
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29141000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.39
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.4
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,598180000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,598180000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,280814000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,280814000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,317410000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,207537000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,59287000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,266824000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,50586000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,151000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4849000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,45789000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6697000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,39092000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,38992000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,38992000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28876000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.35
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29133000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.34
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.35
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,472821000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,472821000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,202715000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,202715000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,270106000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,188555000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,47202000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,235757000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,34349000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5002000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2653000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7655000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,26694000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8876000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,17818000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,17818000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,17818000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29092000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.61
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29289000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.61
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.61
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,506102000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,506102000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,226505000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,226505000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,279597000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,192845000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,46547000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,239392000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,40205000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4834000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4169000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-665000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,39540000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11117000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,28423000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,28423000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,28423000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29136000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.98
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29381000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.97
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.98
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,469961000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,469961000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,206509000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,206509000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,263452000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,187445000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,43336000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,230781000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,32671000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5822000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1466000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7288000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,25400000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8045000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,17355000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,17355000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,17370000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29195000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.59
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29439000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.59
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29400000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.59
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,570516000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,570516000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,262042000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,262042000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,308515000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,193145000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,55887000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,249032000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,59483000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6034000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,801000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5233000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,54166000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8562000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,45604000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,45604000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,45589000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29186000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.56
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29409000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.54
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.56
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,471197000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,471197000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,207168000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,207168000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,264029000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,189716000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,48586000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,238302000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,25727000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5580000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,71000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5509000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,20200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7919000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12281000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12276000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12276000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29364000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.42
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29506000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.42
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.42
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,516777000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,516777000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,236545000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,236545000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,280232000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,205536000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,49811000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,2360000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,257707000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,22525000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5632000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,9963000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4331000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,26900000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8850000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18050000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,18050000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,18014000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29398000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.61
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29589000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.61
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29500000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.61
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,508745000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,508745000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,229276000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,229276000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,279469000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,201452000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,49924000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,251376000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,28093000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5634000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,190000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5444000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,22700000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4283000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18417000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,18417000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,18405000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29444000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.63
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29671000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.62
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.63
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,571453000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,571453000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,256755000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,256755000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,314698000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,217993000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,57387000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,59940000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,335320000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-20627000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6534000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-966000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7500000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-5452000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22748000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22743000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22695000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29440000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.78
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29646000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.77
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29500000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.78
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,500100000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,500100000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,229988000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,229988000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,270063000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,194402000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,49452000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,243854000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,26209000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5316000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-789000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6105000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,20100000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7734000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12366000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12400000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12400000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29580000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.42
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29911000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.41
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29500000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.42
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,504700000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,504700000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,231291000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,231291000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,273375000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,212489000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,62587000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,275076000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1701000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6045000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,8846000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2801000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1100000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-3915000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5015000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5035000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5035000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29613000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.17
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30006000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.17
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29600000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.17
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,534100000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,534100000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,235133000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,235133000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,299008000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,198169000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,62077000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,260246000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,38762000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5872000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2263000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8135000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,30600000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8521000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,22079000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,22067000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,22067000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29660000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.74
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30052000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.73
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.74
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,621253000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,621253000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,276038000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,276038000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,345257000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,201730000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,76041000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,11506000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,289277000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,55980000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5781000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4225000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10006000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,46005000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-36784000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,82789000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,82747000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,82747000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29655000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.79
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30034000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.76
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29700000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.79
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,551519000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,551519000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,249316000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,249316000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,302203000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,209130000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,49427000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,258557000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,43646000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5782000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,825825000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,820043000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,863689000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,206915000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,656774000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,656774000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,656774000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29787000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,22.05
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30171000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,21.77
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,22.05
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,575911000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,575911000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,274244000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,274244000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,301667000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,210425000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,47450000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,257875000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,43792000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5977000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,302271000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,296294000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,340086000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,72043000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,268043000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,268043000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,268043000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29814000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,8.99
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30219000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,8.87
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,8.99
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,545138000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,545138000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,258422000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,258422000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,286716000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,201196000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,49245000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,250441000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,36275000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6064000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,319920000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,313856000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,350131000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,80805000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,269326000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,269326000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,269326000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29863000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,9.02
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30292000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,8.89
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29900000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,9.02
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,554000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,554000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,242217000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,242217000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,311762000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,207581000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,47575000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,255156000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,56606000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5986000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1076646000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1070660000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1127266000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,262071000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,865195000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,865195000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,865195000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29801000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,29.03
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30104000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,28.74
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,29.03
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,572619000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,572619000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,264850000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,264850000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,307769000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,201257000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,50122000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,251379000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,56390000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5841000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,719052000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,713211000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,769601000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,170791000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,598810000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,598810000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,598810000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29814000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,20.08
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30154000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,19.86
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,20.08
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,560633000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,560633000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,253607000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,253607000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,307026000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,201622000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,47944000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,249566000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,57460000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5525000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-387151000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-392676000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-335216000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-76400000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-258816000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-258816000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-258816000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29831000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-8.68
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29831000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-8.68
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-8.68
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,624407000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,624407000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,293989000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,293989000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,330439000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,214165000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,57069000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,271234000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,59205000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6064000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,646289000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,640225000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,699430000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,145944000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,553486000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,553486000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,553486000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29843000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,18.5
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30184000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,18.35
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,18.5
